Advertisement

Journal of Computer-Aided Molecular Design

, Volume 21, Issue 10–11, pp 591–601 | Cite as

Computer-aided drug design: the next 20 years

  • John H. Van Drie
Article

Abstract

This perspectives article has been taken from a talk the author gave at the symposium in honor of Yvonne C. Martin’s retirement, held at the American Chemical Society spring meeting in Chicago on March 25, 2007. The talk was intended as a somewhat lighthearted attempt to gaze into the future; inevitably, in print, things will come across more seriously than was intended. As we all know—the past is rarely predictive of the future.

Keywords

Thermodynamics Pharmacophores CoMFA ADME models Protein–protein interactions 

References

  1. 1.
    Martin YC (1992) J Med Chem 35:2145; Van Drie JH, Weininger D, Martin YC (1989) J Comput Aided Mol Des 3:255; Kebabian JW et al (1990) Am J Hypertens 3:40S (the events described therein took place in the summer of 1987)Google Scholar
  2. 2.
    Rong SB et al (2002) J Med Chem 45:4140. Compare that prediction with the experimental structure published later, Davis MI (2005) Proc Natl Acad Sci USA 102:5981Google Scholar
  3. 3.
    Bezdek J (1993) IEEE Fuzzy Syst 1:1Google Scholar
  4. 4.
    Gund P et al (1980) Science 208:1425CrossRefGoogle Scholar
  5. 5.
    Hartman GD et al (1992) J Med Chem, 35:4640CrossRefGoogle Scholar
  6. 6.
    Gehlhaar DK et al (1995) J Med Chem 38:466CrossRefGoogle Scholar
  7. 7.
    Lipinski CA et al (1998) Adv Drug Deliv Rev, 23:3CrossRefGoogle Scholar
  8. 8.
    McCammon JA, Gelin BR, Karplus M (1977) Nature 267:585CrossRefGoogle Scholar
  9. 9.
    McCammon JA (1987) Science 238:486; van Gunsteren WF, Berendsen HJ (1987) J Comput Aided Mol Des 1:171Google Scholar
  10. 10.
    Guarnieri F, Mezei M (1996) J Am Chem Soc 118:8493CrossRefGoogle Scholar
  11. 11.
    Shuker SB et al (1996) Science 274:1531CrossRefGoogle Scholar
  12. 12.
    Abagyan R et al (1997) Proteins Suppl 1:29; Jacobson MP et al (2004) Proteins 55:351Google Scholar
  13. 13.
    Rezai T et al (2006) J Am Chem Soc 128:14073CrossRefGoogle Scholar
  14. 14.
    deGroot SR, Mazur P (1962) Non-equilibrium thermodynamics. North Holland Pub. Co., AmsterdamGoogle Scholar
  15. 15.
    Dill K et al (2006) Am J Phys 74:123CrossRefGoogle Scholar
  16. 16.
    Kola I, Landis J (2004) Nat Rev Drug Discov 3:711CrossRefGoogle Scholar
  17. 17.
    Sanguinetti MC, Tristani-Firouzi M (2006) Nature 440:463CrossRefGoogle Scholar
  18. 18.
    Pearlstein R et al (2003) Bioorg Med Chem Lett 13:1829–1835CrossRefGoogle Scholar
  19. 19.
    Van Drie JH (2003) In: Bultinck P, De Winter H, Langenaeker W, Tollenaere J (eds) Computational medicinal chemistry and drug discovery. Dekker, New York, pp 437–460Google Scholar
  20. 20.
    Warmuth MK et al (2003) J Chem Inf Comput Sci 43:667CrossRefGoogle Scholar
  21. 21.
    Cramer RD, Patterson DE, Bunce JD (1988) J Am Chem Soc 110:5959CrossRefGoogle Scholar
  22. 22.
    Klebe G et al (1994) J Med Chem 37:4130CrossRefGoogle Scholar
  23. 23.
    Cramer RD, Wendt B (2007) J Comput Aided Mol Des 21:23CrossRefGoogle Scholar
  24. 24.
    Van Drie JH (2003) Curr Pharm Des 19:1649CrossRefGoogle Scholar
  25. 25.
    Cavalli A et al (2002) J Med Chem 45:3844CrossRefGoogle Scholar
  26. 26.
    Ondetti MA, Cushman DW, Rubin B (1983) Captopril. In: Bindra JS, Lednicer D (eds) Chronicles of drug discovery. Wiley, NY, pp 1–31Google Scholar
  27. 27.
    Keskin O et al (2007) Curr Top Med Chem 7:943CrossRefGoogle Scholar
  28. 28.
    Welsh SJ et al (2006) Semin Oncol 33:486CrossRefGoogle Scholar
  29. 29.
    Sharma SK, Straub C, Zawel L (2006) Int J Pept Res Ther 12:21CrossRefGoogle Scholar
  30. 30.
    Tovar C et al (2006) Proc Natl Acad Sci USA 103:1888CrossRefGoogle Scholar
  31. 31.
    ENCODE Project Consortium (2007) Nature 447:799CrossRefGoogle Scholar
  32. 32.
    Viger A, Dervan PB (2006) Bioorg Med Chem 14:8539CrossRefGoogle Scholar
  33. 33.
    Kontoghiorghes GJ (2006) Expert Opin Emerg Drugs 11:1CrossRefGoogle Scholar
  34. 34.
    Silva GA et al (2004) Science 303:1352CrossRefGoogle Scholar
  35. 35.
    Peyssonnaux CC (2001) Biol Cell 93:53CrossRefGoogle Scholar
  36. 36.
    Ohren JF et al (2004) Nat Struct Mol Biol 11:1192CrossRefGoogle Scholar
  37. 37.
    Kirschner MW (2005) Cell 121:503CrossRefGoogle Scholar
  38. 38.
    Perelson AS et al (1996) Science 271:1582CrossRefGoogle Scholar
  39. 39.
    Dahari H et al (2007) J Theor Biol 247:371CrossRefGoogle Scholar
  40. 40.
    Aguda BD (1999) Proc Natl Acad Sci USA 96:11352CrossRefGoogle Scholar
  41. 41.
    Terman D et al (2002) J Neurosci 22:2963Google Scholar
  42. 42.
  43. 43.
    Abagyan R (2006) Trends Biochem Sci 31:76CrossRefGoogle Scholar
  44. 44.
    Alvarez J, Shoichet B (2005) Virtual screening. CRC Press, Boca RatonGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2007

Authors and Affiliations

  1. 1.John H Van Drie Research LLCAndoverUSA

Personalised recommendations